Kaneva Tablet 100 mg contains Erlotinib, a targeted anticancer medicine used in the management of specific types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to the class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking signals that promote cancer cell growth and survival.

Kaneva Tablet is prescribed as part of targeted therapy and is especially effective in patients whose cancer cells express mutations in the epidermal growth factor receptor (EGFR). By specifically targeting cancer-related pathways, Kaneva helps slow disease progression while minimizing damage to normal cells compared to traditional chemotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Erlotinib works by selectively inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. EGFR plays a crucial role in:

• Cancer cell proliferation

• Tumor angiogenesis

• Metastasis and disease progression

By blocking EGFR signaling, Kaneva Tablet:

• Prevents cancer cells from multiplying

• Induces apoptosis (programmed cell death)

• Helps control tumor growth and spread

This targeted mechanism makes Erlotinib an important option in modern oncology treatment protocols.

Therapeutic Indications

Kaneva Tablet 100 mg is indicated for:

• Non-small cell lung cancer (NSCLC), particularly in patients with EGFR-positive tumors

• Advanced or metastatic pancreatic cancer, often in combination with other anticancer agents

• Maintenance or second-line therapy in selected cancer patients as advised by an oncologist

Treatment is individualized based on cancer type, stage, and patient response.

Dosage and Administration

• Kaneva Tablet should be taken exactly as prescribed by a qualified oncologist.

• Usually taken once daily on an empty stomach, either 1 hour before or 2 hours after meals.

• Tablets should be swallowed whole with water and not crushed or chewed.

• Treatment duration depends on disease progression and patient tolerance.

Strict adherence to the prescribed schedule is essential to achieve optimal therapeutic outcomes.

Safety Information and Precautions

• Kaneva Tablet is intended for use under strict medical supervision.

• Use with caution in patients with liver impairment, lung disease, or severe skin disorders.

• Smoking can reduce the effectiveness of Erlotinib and should be avoided during treatment.

• Regular monitoring of liver function and clinical response may be required during therapy.

Patients should inform their healthcare provider about all other medicines they are taking to avoid potential drug interactions.

Possible Side Effects

Like other targeted cancer therapies, Kaneva Tablet may cause side effects, although not all patients experience them. Commonly reported effects may include:

• Skin rash or dryness

• Diarrhea

• Fatigue

• Loss of appetite

Any persistent or severe symptoms should be reported to a healthcare professional promptly.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store below 30°C in a dry place.

• Protect from light and moisture.

• Keep out of reach of children.

Key Benefits of Kaneva Tablet

• Targeted therapy with specific action on cancer cells

• Helps slow tumor growth and disease progression

• Oral administration for convenient dosing

• Plays a vital role in EGFR-positive cancer management

Kaneva Tablet 100 mg (Erlotinib) represents a focused and effective approach in cancer treatment, offering patients a modern targeted therapy option under professional medical guidance.